Cyclosporine

Organ Transplant Rejection

Cyclosporine is most commonly prescribed to prevent the body from rejecting a newly transplanted organ, such as a kidney, liver, or heart. It is typically used in combination with other medications, such as corticosteroids, to help the immune system accept the new organ.

Autoimmune and Skin Conditions

This medication is also used to manage specific long-term health conditions when other treatments have not been effective:

• Rheumatoid Arthritis: It can help treat severe cases of rheumatoid arthritis by reducing joint inflammation and pain.
• Psoriasis: It is used for adults with severe, disabling psoriasis that has not responded to other therapies.

Chronic Dry Eye

In its ophthalmic (eye drop) form, cyclosporine is used to increase tear production in people with chronic dry eye caused by inflammation. This helps improve eye comfort and health in patients whose tear production is suppressed due to keratoconjunctivitis sicca.

Mechanism of Action

Cyclosporine belongs to a class of medications known as immunosuppressants. Its primary function is to lower the activity of the immune system, which is the body's natural defense against foreign substances.

Targeting White Blood Cells

The medication specifically targets a type of white blood cell called T-lymphocytes, or T-cells. Under normal circumstances, these cells help the body fight off infections. However, in certain medical situations, these cells can cause health problems:

• Organ Transplantation: After a transplant, the immune system may recognize the new organ as a foreign object and try to destroy it. Cyclosporine suppresses the T-cells to prevent them from attacking and rejecting the transplanted kidney, liver, or heart.
• Autoimmune Disorders: In conditions such as rheumatoid arthritis or psoriasis, the immune system becomes overactive and mistakenly attacks the body's own healthy tissues. Cyclosporine helps reduce this overactive response, which can decrease joint inflammation or skin cell buildup.

Ophthalmic Use

When used as an eye drop, cyclosporine is thought to act as a partial immunomodulator. It helps increase the eyes' ability to produce tears by reducing inflammation in the glands that produce tears. This is used for individuals whose tear production is suppressed due to inflammation in the eye area.

Common Side Effects

• Headache
• Nausea, vomiting, or diarrhea
• Heartburn or gas
• Increased hair growth on the face or body
• Acne
• Shaking or tremors
• Muscle or joint pain
• Numbness or tingling in the hands or feet
• Swollen or bleeding gums
• Flushing

For eye drops, common side effects include eye burning, redness, discharge, or a feeling that something is in the eye.

Serious Side Effects

Contact a healthcare provider immediately if you experience:

• Signs of infection, such as fever, chills, or sore throat
• Unusual bruising or bleeding
• Yellowing of the skin or eyes (jaundice)
• Dark urine or pale stools
• Pain in the upper right stomach area
• Changes in urination or swelling of the legs, ankles, or feet
• Seizures or loss of consciousness
• Confusion or vision changes
• Severe headache

Serious Risks and Boxed Warnings

Cyclosporine carries significant risks that require close medical supervision. The most serious warnings include:

• Increased Infection Risk: Because it suppresses the immune system, cyclosporine increases the risk of developing severe bacterial, viral, fungal, and protozoal infections. These infections can be fatal.
• Malignancy: There is an increased risk of developing lymphomas and other cancers, particularly skin cancer. Patients are advised to limit exposure to sunlight and UV light.
• Kidney Damage (Nephrotoxicity): Cyclosporine can cause significant kidney impairment. Monitoring of serum creatinine and blood urea nitrogen is essential to detect dose-related toxicity.
• Hypertension: High blood pressure is a frequent side effect that may require medical treatment.

Interchangeability of Brands

Different formulations of cyclosporine, such as modified (Neoral, Gengraf) and non-modified (Sandimmune) versions, are not bioequivalent. They absorb differently in the body and cannot be swapped for one another without direct medical oversight and blood level monitoring to ensure safety and effectiveness.

Additional Precautions

Healthcare providers typically monitor for several other potential complications during treatment:

• Liver Toxicity: The drug can cause liver injury or dysfunction, requiring periodic liver function tests.
• Nervous System Effects: Potential neurotoxicity may manifest as tremors, convulsions, or changes in mental status.
• Electrolyte Changes: Treatment may lead to high potassium levels (hyperkalemia) or low magnesium levels.
• Vaccinations: Live vaccines should be avoided during treatment because the immune system may not respond appropriately, or the vaccine could cause infection.

Cyclosporine may cause harm to an unborn baby if used during pregnancy. It is also known to pass into breast milk, and breastfeeding is generally not recommended while using this medication.

Pregnancy

Cyclosporine crosses the placenta and reaches the developing fetus. Clinical data suggest that infants exposed to systemic cyclosporine during pregnancy may have a higher risk of being born prematurely or having a lower birth weight. It is not always clear if these risks are due to the medication or the mother's underlying health conditions, such as an organ transplant.

Systemic forms of cyclosporine are generally used during pregnancy only when the potential medical benefit to the mother outweighs the potential risks to the fetus. Individuals who are pregnant or planning to become pregnant should consult their healthcare provider to discuss the risks and benefits of continued treatment.

Breastfeeding

Systemic cyclosporine passes into breast milk and may cause serious adverse effects in a nursing infant. Because of these risks, healthcare providers typically recommend that patients either avoid breastfeeding while taking the medication or discontinue the drug if breastfeeding is necessary. The decision depends on the importance of the medication to the mother's health.

While the amount of medication absorbed into the body from ophthalmic (eye) drops is very low, it is still recommended to discuss the use of these drops with a doctor if you are breastfeeding.

Oral Formulations

Cyclosporine is commonly administered by mouth. These oral products are categorized into two types that are not interchangeable:

• Modified Formulations: These include capsules and oral solutions designed for improved absorption.
• Non-modified Formulations: These include capsules and oral solutions that have different absorption characteristics than the modified versions.

Injectable Formulations

For patients who cannot take medication by mouth, cyclosporine is available as a solution for intravenous infusion. This form is typically administered by a healthcare professional in a hospital or clinical setting.

Ophthalmic Formulations

Cyclosporine is also available as an ophthalmic emulsion. This formulation is used specifically as eye drops for the treatment of certain ocular conditions.

FDA-Approved Indications

Cyclosporine is approved by the U.S. Food and Drug Administration (FDA) for several clinical uses across different formulations:

• Organ Transplantation: Used to prevent the rejection of kidney, liver, and heart transplants. It is typically used in combination with adrenal corticosteroids.
• Autoimmune Conditions: Approved for the treatment of severe, active rheumatoid arthritis and severe recalcitrant plaque psoriasis in patients who have not responded to other systemic therapies.
• Ophthalmic Use: Approved as an eye emulsion to increase tear production in patients whose tear production is suppressed due to ocular inflammation associated with keratoconjunctivitis sicca (dry eye).

Boxed Warnings

The FDA has issued several boxed warnings for systemic cyclosporine due to the risk of serious adverse effects:

• Infection and Malignancy: Increased susceptibility to serious infections and the potential development of lymphomas and other malignancies, particularly of the skin.
• Kidney Toxicity: Cyclosporine can cause nephrotoxicity (kidney damage), which may be dose-related and requires frequent monitoring.
• Hypertension: The medication frequently causes high blood pressure, which must be managed during treatment.
• Formulation Bioequivalence: Different oral formulations (modified versus non-modified) are not bioequivalent and cannot be used interchangeably without physician supervision and blood level monitoring.

Regulatory Requirements

Due to its narrow therapeutic index and potential for toxicity, patients taking systemic cyclosporine require frequent laboratory monitoring. This includes regular blood pressure checks, kidney function tests, and monitoring of the drug concentration levels in the blood to ensure safety and efficacy.

It is critical to take cyclosporine exactly as directed by a healthcare provider. Stopping the medication abruptly or missing doses can have significant consequences depending on why the drug was prescribed:

• Organ Transplant Rejection: For patients who have received a kidney, liver, or heart transplant, cyclosporine prevents the immune system from attacking the new organ. If the medication is stopped, the risk of organ rejection increases significantly, which can lead to organ failure.
• Return of Symptoms: For individuals taking cyclosporine for rheumatoid arthritis or psoriasis, stopping the drug may cause symptoms to return or become more severe than they were before treatment.

Cyclosporine does not typically cause physical withdrawal symptoms like those seen with habit-forming medications. However, because of the risks associated with stopping treatment, you should never discontinue this medication without consulting your doctor first. If you need to stop taking cyclosporine, your healthcare provider will determine the safest way to manage your condition or transition to a different therapy.